CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionWealth Enhancement Advisory Services, Llc
Latest Disclosed Ownership170,856 shares
Latest Disclosed Value $ 49,204,601
Wealth Enhancement Advisory Services, Llc reports 23.72% decrease in ownership of MX4A / CME Group Inc.

On April 8, 2026 - Wealth Enhancement Advisory Services, Llc filed a 13F-HR form disclosing ownership of 170,856 shares of CME Group Inc. (BG:MX4A) valued at $49,204,601 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 223,986 shares of CME Group Inc.. This represents a change in shares of -23.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F CME GROUP COM 12572Q105 170,856 -53,130 -23.72 49,205 -18.28 0.1002
2026-01-08 2025-12-31 13F CME GROUP COM 12572Q105 223,986 120,931 117.35 60,208 121.64 0.0817
2025-10-29 2025-09-30 13F CME GROUP COM 12572Q105 103,055 -1,270 -1.22 27,165 -5.89 0.0411
2025-07-10 2025-06-30 13F CME GROUP COM 12572Q105 104,325 -719 -0.68 28,867 3.58 0.0477
2025-04-16 2025-03-31 13F CME GROUP COM 12572Q105 105,044 40,592 62.98 27,867 86.19 0.0533
2025-03-17 2024-12-31 13F/A-1 CME GROUP COM 12572Q105 64,452 2,686 4.35 14,968 9.83 0.0287
2025-01-10 2024-12-31 13F CME GROUP COM 12572Q105 61,934 168 13,666 0.0276
2024-10-24 2024-09-30 13F CME GROUP COM 12572Q105 61,766 13,561 28.13 13,629 43.80 0.0293
2024-07-16 2024-06-30 13F CME GROUP COM 12572Q105 48,205 8,443 21.23 9,477 10.71 0.0225
2024-04-15 2024-03-31 13F CME GROUP COM 12572Q105 39,762 -48 -0.12 8,560 2.10 0.0221
2024-01-30 2023-12-31 13F CME GROUP COM 12572Q105 39,810 5,971 17.65 8,384 23.75 0.0244
2023-11-13 2023-09-30 13F CME GROUP COM 12572Q105 33,839 33,839 6,775 0.0223
2023-07-21 2023-06-30 13F CME GROUP COM 12572Q105 0 -24,477 -100.00 0 -100.00
2023-04-25 2023-03-31 13F CME GROUP COM 12572Q105 24,477 24,477 4,688 0.0546
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.